Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
DigitalBridge
DBRG
$2.94B
| $4.77M | ﹤0.01% |
195,954
-93,980
| -32% | -$2.31M |
|
2927
Nektar Therapeutics
NKTR
$2.49B
| $4.77M | ﹤0.01% |
5,216
-22,990
| -82% | -$19.6M |
|
|
BPL
2928
CALL
DELISTED
Buckeye Partners, L.P.
BPL
| $4.77M | ﹤0.01% |
133,500
+105,300
| +373% | +$3.77M |
|
2929
Compass Minerals
CMP
$1.11B
| $4.77M | ﹤0.01% |
70,915
+6,803
| +11% | +$444K |
|
2930
CALL
IQVIA
IQV
$39B
| $4.76M | ﹤0.01% |
36,700
+13,700
| +60% | +$1.65M |
|
2931
Adeia
ADEA
$3.29B
| $4.76M | ﹤0.01% |
1,211,619
-134,360
| -10% | -$572K |
|
2932
PUT
National Beverage
FIZZ
$2.93B
| $4.76M | ﹤0.01% |
81,600
-15,800
| -16% | -$887K |
|
2933
CALL
Annaly Capital Management
NLY
$17.6B
| $4.76M | ﹤0.01% |
116,275
+82,200
| +241% | +$3.44M |
|
|
MZOR
2934
CALL
DELISTED
Mazor Robotics Ltd.
MZOR
| $4.75M | ﹤0.01% |
81,500
+47,400
| +139% | +$2.53M |
|
2935
CALL
Entergy
ETR
$50.3B
| $4.75M | ﹤0.01% |
117,000
+12,600
| +12% | +$521K |
|
2936
Progress Software
PRGS
$1.79B
| $4.74M | ﹤0.01% |
134,438
-143,166
| -52% | -$5.68M |
|
2937
PUT
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $4.74M | ﹤0.01% |
115,700
+39,600
| +52% | +$1.67M |
|
2938
PUT
ProShares Ultra QQQ
QLD
$14.4B
| $4.74M | ﹤0.01% |
376,800
-424,000
| -53% | -$5.07M |
|
2939
ProShares Ultra Bloomberg Crude Oil
UCO
$430M
| $4.74M | ﹤0.01% |
21,096
+12,781
| +154% | +$2.5M |
|
2940
CALL
Sanofi
SNY
$105B
| $4.74M | ﹤0.01% |
106,100
+9,500
| +10% | +$406K |
|
2941
CALL
RingCentral
RNG
$5.39B
| $4.74M | ﹤0.01% |
50,900
+33,800
| +198% | +$2.92M |
|
2942
PUT
Canadian Natural Resources
CNQ
$98.9B
| $4.73M | ﹤0.01% |
295,682
-7,351
| -2% | -$124K |
|
2943
McGrath RentCorp
MGRC
$2.99B
| $4.72M | ﹤0.01% |
86,707
+54,767
| +171% | +$3.19M |
|
2944
iShares MSCI Intl Quality Factor ETF
IQLT
$14.3B
| $4.71M | ﹤0.01% |
+159,499
| New | +$4.67M |
|
2945
Element Solutions
ESI
$9.46B
| $4.71M | ﹤0.01% |
377,550
+134,072
| +55% | +$1.67M |
|
2946
Dycom Industries
DY
$12.6B
| $4.71M | ﹤0.01% |
55,634
-219,952
| -80% | -$19M |
|
2947
CALL
Itaú Unibanco
ITUB
$81.6B
| $4.71M | ﹤0.01% |
883,350
+453,116
| +105% | +$2.44M |
|
|
SONC
2948
CALL
DELISTED
Sonic Corp
SONC
| $4.7M | ﹤0.01% |
108,500
+70,600
| +186% | +$2.54M |
|
2949
US Physical Therapy
USPH
$1.21B
| $4.7M | ﹤0.01% |
39,621
+1,132
| +3% | +$128K |
|
2950
CDW
CDW
$17.4B
| $4.7M | ﹤0.01% |
52,814
+5,961
| +13% | +$516K |
|
Similar funds
Citadel Advisors's Q3 2018 Portfolio in Review
As of Q3 2018, Citadel Advisors held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Citadel Advisors's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Citadel Advisors added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Citadel Advisors's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Citadel Advisors fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Citadel Advisors opened 1,427 new positions and closed 1,043 in Q3 2018.
- Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.